Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Tolylfluanide-d7

Tolylfluanide-d7

NA

DISCOVER
Trimethoxybenzoate methyl 3,4,5

Trimethoxybenzoate methyl 3,4,5

1916-07-0

DISCOVER
2-Isopropyl-N,2,3-trimethylbutanamide

2-Isopropyl-N,2,3-trimethylbutanamide

51115-67-4

DISCOVER
Urea USP

Urea USP

57-13-6

DISCOVER
2-Fluoro-3-ureidopropionic Acid

2-Fluoro-3-ureidopropionic Acid

5006-64-4

DISCOVER
Valganciclovir HCl

Valganciclovir HCl

175865-59-5

DISCOVER
Vandetanib

Vandetanib

443913-73-3

DISCOVER
Vemurafenib

Vemurafenib

918504-65-1

DISCOVER
Warfarin sodium clathrate

Warfarin sodium clathrate

129-06-6

DISCOVER
Ziprasidone

Ziprasidone

146939-27-7

DISCOVER
Zimelidine diHCl

Zimelidine diHCl

61129-30-4

DISCOVER